Reliability  ||| S:0 E:12 ||| NNP
and  ||| S:12 E:16 ||| CC
acceptance  ||| S:16 E:27 ||| NN
of  ||| S:27 E:30 ||| IN
the  ||| S:30 E:34 ||| DT
mini-clinical  ||| S:34 E:48 ||| JJ
evaluation  ||| S:48 E:59 ||| NN
exercise  ||| S:59 E:68 ||| NN
as  ||| S:68 E:71 ||| IN
a  ||| S:71 E:73 ||| DT
performance  ||| S:73 E:85 ||| NN
assessment  ||| S:85 E:96 ||| NN
of  ||| S:96 E:99 ||| IN
practicing  ||| S:99 E:110 ||| VBG
physicians  ||| S:110 E:121 ||| NNS
The  ||| S:121 E:125 ||| DT
purpose  ||| S:125 E:133 ||| NN
of  ||| S:133 E:136 ||| IN
this  ||| S:136 E:141 ||| DT
study  ||| S:141 E:147 ||| NN
was  ||| S:147 E:151 ||| VBD
to  ||| S:151 E:154 ||| TO
evaluate  ||| S:154 E:163 ||| VB
the  ||| S:163 E:167 ||| DT
reliability  ||| S:167 E:179 ||| NN
and  ||| S:179 E:183 ||| CC
acceptance  ||| S:183 E:194 ||| NN
of  ||| S:194 E:197 ||| IN
the  ||| S:197 E:201 ||| DT
mini-Clinical  ||| S:201 E:215 ||| JJ
Evaluation  ||| S:215 E:226 ||| NNP
Exercise  ||| S:226 E:235 ||| NNP
( ||| S:235 E:236 ||| -LRB-
mini-CEX ||| S:236 E:244 ||| NNP
)  ||| S:244 E:246 ||| -RRB-
as  ||| S:246 E:249 ||| IN
an  ||| S:249 E:252 ||| DT
assessment  ||| S:252 E:263 ||| NN
of  ||| S:263 E:266 ||| IN
practicing  ||| S:266 E:277 ||| VBG
primary  ||| S:277 E:285 ||| JJ
care  ||| S:285 E:290 ||| NN
physicians ||| S:290 E:300 ||| NNS
.  ||| S:300 E:302 ||| .
Six  ||| S:302 E:306 ||| CD
raters  ||| S:306 E:313 ||| NNS
were  ||| S:313 E:318 ||| VBD
recruited  ||| S:318 E:328 ||| VBN
to  ||| S:328 E:331 ||| TO
conduct  ||| S:331 E:339 ||| VB
the  ||| S:339 E:343 ||| DT
assessments ||| S:343 E:354 ||| NNS
.  ||| S:354 E:356 ||| .
After  ||| S:356 E:362 ||| IN
a  ||| S:362 E:364 ||| DT
training  ||| S:364 E:373 ||| NN
session ||| S:373 E:380 ||| NN
,  ||| S:380 E:382 ||| ,
their  ||| S:382 E:388 ||| PRP$
ability  ||| S:388 E:396 ||| NN
to  ||| S:396 E:399 ||| TO
discriminate  ||| S:399 E:412 ||| VB
between  ||| S:412 E:420 ||| IN
levels  ||| S:420 E:427 ||| NNS
of  ||| S:427 E:430 ||| IN
performance  ||| S:430 E:442 ||| NN
was  ||| S:442 E:446 ||| VBD
evaluated  ||| S:446 E:456 ||| VBN
using  ||| S:456 E:462 ||| VBG
videotaped  ||| S:462 E:473 ||| JJ
clinical  ||| S:473 E:482 ||| JJ
scenarios ||| S:482 E:491 ||| NNS
.  ||| S:491 E:493 ||| .
Fifteen  ||| S:493 E:501 ||| JJ
physicians  ||| S:501 E:512 ||| NNS
were  ||| S:512 E:517 ||| VBD
assessed  ||| S:517 E:526 ||| VBN
in  ||| S:526 E:529 ||| IN
an  ||| S:529 E:532 ||| DT
office  ||| S:532 E:539 ||| NN
setting  ||| S:539 E:547 ||| VBG
by  ||| S:547 E:550 ||| IN
the  ||| S:550 E:554 ||| DT
raters  ||| S:554 E:561 ||| NN
who  ||| S:561 E:565 ||| WP
scored  ||| S:565 E:572 ||| VBD
multiple  ||| S:572 E:581 ||| JJ
clinical  ||| S:581 E:590 ||| JJ
encounters  ||| S:590 E:601 ||| NNS
using  ||| S:601 E:607 ||| VBG
a  ||| S:607 E:609 ||| DT
validated  ||| S:609 E:619 ||| JJ
mini-CEX  ||| S:619 E:628 ||| JJ
form  ||| S:628 E:633 ||| NN
for  ||| S:633 E:637 ||| IN
each  ||| S:637 E:642 ||| DT
encounter ||| S:642 E:651 ||| NN
.  ||| S:651 E:653 ||| .
Participants  ||| S:653 E:666 ||| NNS
were  ||| S:666 E:671 ||| VBD
given  ||| S:671 E:677 ||| VBN
a  ||| S:677 E:679 ||| DT
postassessment  ||| S:679 E:694 ||| JJ
survey  ||| S:694 E:701 ||| NN
regarding  ||| S:701 E:711 ||| VBG
the  ||| S:711 E:715 ||| DT
process ||| S:715 E:722 ||| NN
.  ||| S:722 E:724 ||| .
Raters  ||| S:724 E:731 ||| NNP
distinguished  ||| S:731 E:745 ||| VBD
between  ||| S:745 E:753 ||| IN
performance  ||| S:753 E:765 ||| NN
levels  ||| S:765 E:772 ||| NNS
on  ||| S:772 E:775 ||| IN
the  ||| S:775 E:779 ||| DT
videotaped  ||| S:779 E:790 ||| JJ
scenarios  ||| S:790 E:800 ||| NNS
( ||| S:800 E:801 ||| -LRB-
P  ||| S:801 E:803 ||| NNP
< ||| S:803 E:805 ||| SYM
.001 ||| S:805 E:809 ||| NNP
) ||| S:809 E:810 ||| -RRB-
.  ||| S:810 E:812 ||| .
A  ||| S:812 E:814 ||| DT
total  ||| S:814 E:820 ||| NN
of  ||| S:820 E:823 ||| IN
188  ||| S:823 E:827 ||| CD
physician-patient  ||| S:827 E:845 ||| JJ
interactions  ||| S:845 E:858 ||| NNS
were  ||| S:858 E:863 ||| VBD
assessed ||| S:863 E:871 ||| VBN
.  ||| S:871 E:873 ||| .
The  ||| S:873 E:877 ||| DT
generalizability  ||| S:877 E:894 ||| JJ
coefficient  ||| S:894 E:906 ||| NN
for  ||| S:906 E:910 ||| IN
10  ||| S:910 E:913 ||| CD
encounters  ||| S:913 E:924 ||| NNS
was  ||| S:924 E:928 ||| VBD
0.92 ||| S:928 E:932 ||| CD
.  ||| S:932 E:934 ||| .
In  ||| S:934 E:937 ||| IN
the  ||| S:937 E:941 ||| DT
postassessment  ||| S:941 E:956 ||| JJ
survey ||| S:956 E:962 ||| NN
,  ||| S:962 E:964 ||| ,
the  ||| S:964 E:968 ||| DT
raters  ||| S:968 E:975 ||| NN
( ||| S:975 E:976 ||| -LRB-
94 ||| S:976 E:978 ||| CD
% ||| S:978 E:979 ||| NN
)  ||| S:979 E:981 ||| -RRB-
and  ||| S:981 E:985 ||| CC
physicians  ||| S:985 E:996 ||| NNS
assessed  ||| S:996 E:1005 ||| VBD
( ||| S:1005 E:1006 ||| -LRB-
75 ||| S:1006 E:1008 ||| CD
% ||| S:1008 E:1009 ||| NN
)  ||| S:1009 E:1011 ||| -RRB-
both  ||| S:1011 E:1016 ||| CC
felt  ||| S:1016 E:1021 ||| VBD
that  ||| S:1021 E:1026 ||| IN
the  ||| S:1026 E:1030 ||| DT
mini-CEX  ||| S:1030 E:1039 ||| NN
is  ||| S:1039 E:1042 ||| VBZ
an  ||| S:1042 E:1045 ||| DT
acceptable  ||| S:1045 E:1056 ||| JJ
assessment ||| S:1056 E:1066 ||| NN
.  ||| S:1066 E:1068 ||| .
The  ||| S:1068 E:1072 ||| DT
mini-CEX  ||| S:1072 E:1081 ||| NN
seems  ||| S:1081 E:1087 ||| VBZ
to  ||| S:1087 E:1090 ||| TO
be  ||| S:1090 E:1093 ||| VB
a  ||| S:1093 E:1095 ||| DT
reliable  ||| S:1095 E:1104 ||| JJ
and  ||| S:1104 E:1108 ||| CC
acceptable  ||| S:1108 E:1119 ||| JJ
instrument  ||| S:1119 E:1130 ||| NN
for  ||| S:1130 E:1134 ||| IN
the  ||| S:1134 E:1138 ||| DT
assessment  ||| S:1138 E:1149 ||| NN
of  ||| S:1149 E:1152 ||| IN
practicing  ||| S:1152 E:1163 ||| VBG
physicians ||| S:1163 E:1173 ||| NNS
.  ||| S:1173 E:1175 ||| .
